SCENESSE: Clinical trials for new vitiligo treatment - part 1
A new drug called Scenesse is being developed and tested by Clinuvel, an Australian company. Currently it is in phase II and III of clinical trials. Clinuvel states that it's product will be an effective therapy in nonsegmental vitiligo (symmetry in the vitiligo spots on one's body).
A clear date for it's commercial release is not yet known.